Cargando…
Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions
AIMS: Overactive bladder (OAB) is common in men and may exist concomitantly with benign prostatic hyperplasia (BPH) and obstruction. We present a subanalysis of results from men with OAB in a 6-month, open-label study of treatment with the oxybutynin transdermal system (OXY-TDS). Broad entry criteri...
Autores principales: | Staskin, D R, Rosenberg, M T, Dahl, N V, Polishuk, P V, Zinner, N R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228367/ https://www.ncbi.nlm.nih.gov/pubmed/17983434 http://dx.doi.org/10.1111/j.1742-1241.2007.01625.x |
Ejemplares similares
-
Transdermal oxybutynin in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2006) -
Development of oxybutynin chloride topical gel for overactive bladder
por: Lucente, Vincent R, et al.
Publicado: (2011) -
Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin
por: Gamble, Tondalaya, et al.
Publicado: (2008) -
Insights into the Management of Overactive Bladder with Transdermal Oxybutynin: A Practical Review
por: Vozmediano-Chicharro, Raúl, et al.
Publicado: (2020) -
Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain
por: Crespo, Carlos, et al.
Publicado: (2018)